Login / Signup
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design.
Carmelo Gurnari
Valeria Visconte
Published in:
British journal of haematology (2021)
Keyphrases
</>
clinical trial
phase ii
open label
double blind
study protocol
phase iii
placebo controlled